<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0039">
 <label>39</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Gouda</surname>
    <given-names>AM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Abdelazeem</surname>
    <given-names>AH</given-names>
   </name>, 
   <name name-style="western">
    <surname>Abdalla</surname>
    <given-names>AN</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ahmed</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Pyrrolizine-5-carboxamides: exploring the impact of various substituents on anti-inflammatory and anticancer activities</article-title>. 
  <source>Acta Pharm</source>
  <year>2018</year>;
  <volume>68</volume>:
  <fpage>251</fpage>â€“
  <lpage>73</lpage>.
  <pub-id pub-id-type="pmid">31259695</pub-id>
 </mixed-citation>
</ref>
